COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,492 Articles (22,862 medRxiv, 8,630 bioRxiv)

Most recent first Previous |  Page 2824: Articles 28231-28240  | Next

Drive-through testing for SARS-CoV-2 in symptomatic health and social care workers and household members: an observational cohort study in Tayside, Scotland
Parcell, B., Brechin, K., Allstaff, S., Park, M., Third, W., Bean, S., Hind, C., Farmer, R., Chalmers, J. D.
10.1101/2020.05.08.20078386 — Posted: 2020-05-11
Structural insight into the putative role of Novel Coronavirus-2 E protein in viral infection via in silico approach: a potential target for LAV development and other therapeutic strategies
Sarkar, M., Saha, S.
10.1101/2020.05.11.088781 — Posted: 2020-05-11
Evidence for strong mutation bias towards, and selection against, T/U content in SARS-CoV2: implications for attenuated vaccine design.
Rice, A. M., Castillo Morales, A., Ho, A. T., Mordstein, C., Mühlhausen, S., Watson, S., Cano, L., Young, B., Kudla, G., Hurst, L. D.
10.1101/2020.05.11.088112 — Posted: 2020-05-11
Rapid isolation of potent SARS-CoV-2 neutralizing antibodies and protection in a small animal model
Rogers, T. F., Zhao, F., Huang, D., Beutler, N., Abbott, R. K., Callaghan, S., Garcia, E., He, W.-t., Hurtado, J., Limbo, O., Parren, M., Peng, L., Ricketts, J., Ricciardi, M. K., Smith, C., Song, G., Woehl, J., Yang, L., Rawlings, S., Smith, D. M., Nemazee, D., Teijaro, J. R., Voss, J. E., Andrabi, R., Briney, B., Landais, E., Sok, D., Jardine, J. G., Burton, D.
10.1101/2020.05.11.088674 — Posted: 2020-05-11 Discussion: Onsite
Activation of the SARS-CoV-2 receptor Ace2 by cytokines through pan JAK-STAT enhancers
Hennighausen, L., Lee, H. K.
10.1101/2020.05.11.089045 — Posted: 2020-05-11
A Rapid, Cost-Effective Tailed Amplicon Method for Sequencing SARS-CoV-2
Gohl, D. M., Garbe, J., Grady, P., Daniel, J., Watson, R. H. B., Auch, B., Nelson, A., Yohe, S., Beckman, K. B.
10.1101/2020.05.11.088724 — Posted: 2020-05-11
Effect of underlying comorbidities on the infection and severity of COVID-19 in South Korea
Ji, W., Huh, K., Kang, M., Hong, J., Bae, G. H., Lee, R., Na, Y., Choi, H., Gong, S., Choi, Y.-H., Ko, K.-P., Im, J.-S., Jung, J.
10.1101/2020.05.08.20095174 — Posted: 2020-05-11 Discussion: Onsite
Transmission in Latent Period Causes A Large Number of Infected People in the United States
Liu, Q., Zhu, J., Liu, Z., Zhu, Y., Zhou, L., Gao, Z., Li, D., Tang, Y., Zhang, X., Yang, J., Wang, Q.
10.1101/2020.05.07.20094086 — Posted: 2020-05-11
Negative nasopharyngeal SARS-CoV-2 PCR conversion in Response to different therapeutic interventions
Shabrawishi, M. H., Naser, A. Y., Alwafi, H., Aldobyany, A. M., Touman, A. A.
10.1101/2020.05.08.20095679 — Posted: 2020-05-11
Early impact of the COVID-19 pandemic and social distancing measures on routine childhood vaccinations in England, January to April 2020
McDonald, H. I., Tessier, E., White, J. M., Woodruff, M., Knowles, C., Bates, C., Parry, J., Walker, J. L., Scott, J. A., Smeeth, L., Yarwood, J., Ramsay, M., Edelstein, M.
10.1101/2020.05.07.20094557 — Posted: 2020-05-11

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).